Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pTR RE-TK hRluc(F) (#RDB05630)

Reporter construct of TR response element

Alternative name 2485C3F
Clone info. Thyroid hormone response element (TRE-DR4) is cloned into the BglII site of phRL-TK, and the BglII site is killed by the cloning. The nucleotide sequence of the TRE is 5'-gatccaggtcaaaaaaggtcag-3'. (Ref: Endocrinol. 135: 1628-1638, 1994)
Comment The nucleotide sequence of the element was determined. Function of the inserted element has not been examined by the depositor.
Vector backbone phRL-TK (Plasmid)
Size of vector backbone 4.0 kb
Selectable markers Amp^r
Gene/insert name Artificial TR response element synthesized
Depositor|Developer Yokoyama, Kazunari |
 
Remarks, protocol and/or map (pdf) RDB05630.pdf

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution The RECIPIENT agrees to expressly describe the acknowledgement of the Gene Engineering Division, RIKEN BRC as the source of the BIOLOGICAL RESOURCE in any publication. The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for-profit organization for a not-for-profit research.
Additional terms and conditions:
The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 リソースを使用して論文を投稿する場合、理研BRC・遺伝子材料開発室から分譲された事を記載する。本件リソースは非営利機関にのみ提供し、非営利研究にのみ利用することができる。
MTAに書く付加的使用条件:
本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。

Catalog # Resource name Shipping form Fee (non-profit org.)
RDB05630 pTR RE-TK hRluc(F) DNA solution

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pTR RE-TK hRluc(F) was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB05630).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB16935_A9C4p1-1.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: SV40pA3'ElementReverse ()
Sequence file: RDB16935_A9C4a.seq check
>05630_16935_A9C4_3_SV40pA3'ElementReverse_A02_01_ABI08.ab1
    1 GGTCGGTTTG GGGGGGGCGG AGCCTATGGA AAACGCCAGC AACGCGGCCT TTTTACGGTT
   61 CCTGGCCTTT TGCTGGCCTT TTGCTCACAT GGCTCGACAG ATCCAGGTCA AAAAAGGTCA
  121 GGATCTAAAT GAGTCTTCGG ACCTCGCGGG GGCCGCTTAA GCGGTGGTTA GGGTTTGTCT
  181 GACGCGGGGG GAGGGGGAAG GAACGAAACA CTCTCATTCG GAGGCGGCTC GGGGTTTGGT
  241 CTTGGTGGCC ACGGGCACGC AGAAGAGCGC CGCGATCCTC TTAAGCACCC CCCCGCCCTC
  301 CGTGGAGGCG GGGGTTTGGT CGGCGGGTGG TAACTGGCGG GCCGCTGACT CGGGCGGGTC
  361 GCGCGCCCCA GAGTGTGACC TTTTCGGTCT GCTCGCAGAC CCCCGGGCGG CGCCGCCGCG
  421 GCGGCGACGG GCTCGCTGGG TCCTAGGCTC CATGGGGACC GTATACGTGG ACAGGCTCTG
  481 GAGCATCCGC ACGACTGCGG TGATATTACC GGAGACCTTC TGCGGGACGA GCCGGGTCAC
  541 GCGGCTGACG CGGAGCGTCC GTTGGGCGAC AAACACCAGG ACGGGGCACA GGTACACTAT
  601 CTTGTCACCC GGAGGCGCGA GGGACTGCAG GAGCTTCAGG GAGTGGCGCA GCTGCTTCAT
  661 CCCCGTGGCC CGTTGCTCGC GTTTGCTGGC GGTGTCCCCG GAAGAAATAT ATTTGCATGT
721 CTTTAGTTCT ATGATGACTC CAACCCCGCC CAGCGTCCTT GT
//
Primer: Tkpro-F ()
Sequence file: RDB16935_A9C4b.seq check
>05630_16935_A9C4_3_Tkpro-F_B02_02_ABI08.ab1
    1 CGGGGTGCCT CGAACCCGAG CGACCCTGCA GCGACCCGCT TAAAAGCTTG ATTCTTCTGA
   61 CACAACAGTC TCGAACTTAA GCTGCAGAAG TTGGTCGTGA GGCACTGGGC AGGTAAGTAT
  121 CAAGGTTACA AGACAGGTTT AAGGAGACCA ATAGAAACTG GGCTTGTCGA GACAGAGAAG
  181 ACTCTTGCGT TTCTGATAGG CACCTATTGG TCTTACTGAC ATCCACTTTG CCTTTCTCTC
  241 CACAGGTGTC CACTCCCAGT TCAATTACAG CTCTTAAGGC TAGAGTACTT AATACGACTC
  301 ACTATAGGCT AGCCACCATG GCTTCCAAGG TGTACGACCC CGAGCAACGC AAACGCATGA
  361 TCACTGGGCC TCAGTGGTGG GCTCGCTGCA AGCAAATGAA CGTGCTGGAC TCCTTCATCA
  421 ACTACTATGA TTCCGAGAAG CACGCCGAGA ACGCCGTGAT TTTTCTGCAT GGTAACGCTG
  481 CCTCCAGCTA CCTGTGGAGG CACGTCGTGC CTCACATCGA GCCCGTGGCT AGATGCATCA
  541 TCCCTGATCT GATCGGAATG GGTAAGTCCG GCAAGAGCGG GAATGGCTCA TATCGCCTCC
  601 TGGATCACTA CAAGTACCTC ACCGCTTGGT TCGAGCTGCT GAACCTTCCA AAGAAAATCA
  661 TCTTTGTGGG CCACGACTGG GGGGCTTGTC TGGCCTTTCA CTACTCCTAC GAGCACCAAG
  721 ACAAGATCAA GGCCATCGTC CATGCTGAGA GTGTCGTGGA CGTGATCGAG TCCTGGGACG
  781 AGTGGCCTGA CATCGAGGAG GATATCGCCC TGATCAAGAG CGAAAGAGGG CGAGAAAATG
  841 GTGCTTGAGA ATAACTTTCT TCGTCGAGAC CATGCTCCCA AGCAAGATCA TGCGGAAACT
  901 GGGAGCCTGA GGAGTTCGCT GCCTACCTGG AGGCCATTCA AGGAGAAGGG CGAGGTTAGA
  961 CGGCCTACCC TCTCCTGGCC TCGCTAGATC CCCTCTCGTT AAGGGAGGAA GCCCGACGTC
1021 GTCCAAATTG TCCGCAACTA CAACGCCTAC CCTTCCGGGC CCGCGACCAA TCTGGCTT
//
Primer: pGCAP_R ()
Sequence file: RDB16935_A9C4c.seq check
>05630_16935_A9C4_3_pGCAP_R_C02_03_ABI08.ab1
    1 CGGGAAACTT ATCATGTCTG CTCGAAGCGG CCGCTCTAGA ATTACTGCTC GTTCTTCAGC
   61 ACGCGCTCCA CGAAGCTCTT GATGTACTTA CCCATTTCAT CTGGAGCGTC CTCCTGGCTG
  121 AAGTGGAGGC CCTTCACCTT CACGAACTCG GTGTTAGGGA ACTTCTTAGC TCCCTCGACA
  181 ATAGCGTTGG AAAAGAACCC AGGGTCGGAC TCGATGAACA TCTTAGGCAG ATCGTCGCTG
  241 GCCCGAAGGT AGGCGTTGTA GTTGCGGACA ATCTGGACGA CGTCGGGCTT GCCTCCCTTA
  301 ACGAGAGGGA TCTCGCGAGG CCAGGAGAGG GTAGGCCGTC TAACCTCGCC CTTCTCCTTG
  361 AATGGCTCCA GGTAGGCAGC GAACTCCTCA GGCTCCAGTT TCCGCATGAT CTTGCTTGGG
  421 AGCATGGTCT CGACGAAGAA GTTATTCTCA AGCACCATTT TCTCGCCCTC TTCGCTCTTG
  481 ATCAGGGCGA TATCCTCCTC GATGTCAGGC CACTCGTCCC AGGACTCGAT CACGTCCACG
  541 ACACTCTCAG CATGGACGAT GGCCTTGATC TTGTCTTGGT GCTCGTAGGA GTAGTGAAAG
  601 GCCAGACAAG CCCCCCAGTC GTGGCCCACA AAGATGATTT TCTTTGGAAG GTTCAGCAGC
  661 TCGAACCAAG CGGTGAGGTA CTTGTAGTGA TCCAGGAGGC GATATGAGCC ATTCCCGCTC
  721 TTGCCGGACT TACCCATTCC GATCAGATCA GGGATGATGC ATCTAGCCAC GGGCTCGATG
  781 TGAGGCACGA CGTGCCTCCA CAGGTAGCTG GAGGCAGCGT TACCATGCAG AAAAATCACG
  841 GCGTTCTCGG CGTGCTTCTC GGAATCATAG TAGTTGATGA AGGGAGTCCA GCACGTTCAT
  901 TTGCTTGCAG CGAGCCCACC ACTGAGGCCC AAGTGATCAT GCGTTTGCGT TGCTCGGGGT
  961 TCGTACACCT TGGAAAGCCA TGGTGGGCTA GCCCTATAGT GAAGTCGTAT TTAAGTACTC
 1021 TTAGCCTTTA AGAGCTGGTA TTTGAACTGG GAAGTGGAAC ACCTGTTGAA GAGAAAGGCA
 1081 AAGTGGGATG TCAGTAGAAC AAATAGGCTG CCTATTCAGA ACCGCAAGAA AGTCTGTGTC
 1141 TGGTCCTCGA CCAGCCCAAT TCTATTTGGT CTTCCGTTAA CCTTGTCTGT GTAACTCTGG
1201 ATTACCCTAC CCTGTCCCGA TGGCGGCCGC TCT
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles